title: Severe acute respiratory syndrome.
abstract: The first cases of severe acute respiratory syndrome (SARS) occurred in China in November 2002. The agent causing this illness has been identified as a novel coronavirus, SARS-coronavirus. Since its introduction <1 year ago, this virus has infected 8098 people in 26 countries, killing 774 of them. We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experience.
authors.affiliation: Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Christian
authors.forename: Susan M
authors.initials: SM
authors.lastname: Poutanen
authors.forename: Mona R
authors.initials: MR
authors.lastname: Loutfy
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Muller
authors.forename: Donald E
authors.initials: DE
authors.lastname: Low
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D021821:Communicable Diseases, Emerging / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D004196:Disease Outbreaks; D006801:Humans; D017053:Infection Control; D017758:Infectious Disease Transmission, Patient-to-Professional; D012254:Ribavirin / Q000627:therapeutic use; D045473:Severe acute respiratory syndrome-related coronavirus; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D014944:World Health Organization
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin